🇺🇸 3TC in United States
539 US adverse-event reports
Safety signals — FAERS
Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.
- Window: 21 April 2025 – 21 April 2026
- Total reports: 539
Most-reported reactions
- Vomiting — 76 reports (14.1%)
- Nausea — 68 reports (12.62%)
- Pneumonia — 57 reports (10.58%)
- Hepatic Enzyme Increased — 53 reports (9.83%)
- Blood Bilirubin Increased — 50 reports (9.28%)
- Hepatotoxicity — 49 reports (9.09%)
- Psychotic Disorder — 48 reports (8.91%)
- Condition Aggravated — 47 reports (8.72%)
- Pyrexia — 47 reports (8.72%)
- Cholelithiasis — 44 reports (8.16%)
Other Infectious Disease approved in United States
Frequently asked questions
Is 3TC approved in United States?
3TC does not currently have US marketing authorisation in our dataset.
Who is the marketing authorisation holder for 3TC in United States?
Avexa is the originator. The local marketing authorisation holder may differ — check the official source linked above.